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Illness cognitions are mediators between illness and wellbeing in patients with physical 
symptoms.  The Illness Cognitions Questionnaire (ICQ) explores these illness cognitions, but 
has not been validated in older persons. This study aimed to validate the ICQ in adults aged 
60 years and above and to develop an extended version (ICQ-plus) suitable for older persons.
Qualitative interviews were conducted to explore illness cognitions in 21 older persons 
suffering physical symptoms. The items in the original ICQ and items of these interviews that 
potentially reflect dimensions not covered by the original ICQ, were combined in the ICQ-plus. 
Then the ICQ-plus was administered to 220 older patients with physical symptoms and its 
factor structure was explored by Maximum Likelihood factor analyses. Analysis of covariance 
(ANCOVA) was performed to assess differences in illness cognitions between older persons 
suffering from medically explained and medically unexplained symptoms.
The interviews had generated 26 new items. Factor analysis confirmed the three factor 
structure of the original ICQ, including factors covering helplessness, disease benefits and 
acceptance. In addition, exploratory factor analysis on the ICQ-plus items revealed four 
additional factors including cognitions referring to perseverance, illness anxiety, avoidance 
and catastrophizing. Patients with MUS scored significantly lower than patients with MES on 
acceptance and disease benefits and higher on helplessness and illness anxiety.  We concluded 
that older patients with physical symptoms, express illness cognitions which are relevant for 
treatment but are not covered by the ICQ and recommend to use the extended ICQ-plus in 




Illness cognitions are the personal meanings given to somatic complaints 1.They are important 
mediators between chronic somatic diseases and patients’ wellbeing 2. In other words, the way 
people think about their disease accounts for their health-related quality of life and way of 
living 2.  Targeting maladaptive illness cognitions, as done in Cognitive Behavioural Therapy 
(CBT), may therefore improve quality of life in patients suffering from physical symptoms 3, 4.
The Illness Cognition Questionnaire (ICQ) has been developed to measure three categories 
of illness cognitions, i.e. acceptance, disease benefits and helplessness. Based on an extensive 
literature review, these categories were presumed to reflect the different ways of reevaluating 
the aversive character of a chronic condition 2, 5. The ICQ was originally developed in a sample 
of middle-aged patients suffering from either rheumatoid arthritis (n=263, mean age of 58.1 
years) or multiple sclerosis (n=167, mean age of 40.6 years) 2. Cross-validation of the ICQ has 
confirmed the three-factor structure also in middle-aged patients with unexplained chronic 
pain (n=821, mean age 50.8 years) and chronic fatigue (n=295, mean age of 40.3 years) 5. The 
three categories of illness cognitions can thus be found in both medically explained- and 
medically unexplained symptoms.
In clinical practice many physical symptoms cannot be ascribed to an explained somatic condition. 
Up to a third of physical symptoms presented in primary care and approximately half presented 
in secondary health care remain unexplained 6-8. Illness cognitions may even be more important 
with respect to quality of life in patients suffering from medically unexplained symptoms (MUS). 
The association between physical symptoms and health-related quality of life is stronger in 
patients suffering from MUS than in patients with medically explained symptoms (MES) 9. 
Our study will address two aspects that have been neglected hitherto, i.e. the validity in old 
age and the implicit assumption of completeness of the ICQ. Cross-validation in populations 
suffering from other diseases or differing on critical factors is important before recommending 
the ICQ in routine clinical care 10. Age may be such a critical factor and is especially relevant 
acknowledging the steep increase of physical symptoms with age 11. Previous studies in both 
psychiatric and somatic disorders have indeed shown that illness cognitions change across 
the lifespan12,-14. Furthermore, the ICQ has been developed specifically to cover three predefined 
categories, especially with respect to age-specific cognitions in the oldest-old. Knowledge 
of specific illness cognitions in older people is important to improve effectiveness of CBT 
for older patients. Hitherto, CBT is the most promising treatment strategy for patients 
with maladaptive cognitions in medically explained- and unexplained symptoms 4, 7, 15, 17. 
Unfortunately, CBT has not formally been tested in older patients suffering from physical 
symptoms (MUS and MES). For this purpose, better insight and completeness of potentially 
maladaptive cognitions is crucial.
The primary aim of this study is validate and extend the ICQ in a sample of older persons. 
First, we will explore in a qualitative study the illness cognitions of older people with physical 
symptoms explained and/or unexplained using a semi-structured interview. Subsequently, 
these cognitions will be translated into items that will be added to the ICQ and validated in a 




The Illness Cognition Questionnaire
The Illness Cognition Questionnaire (ICQ) is an 18-item scale that measures the personal 
perception of an individual’s own illness and ability to function 2,5. The ICQ has three 
scales, i.e. acceptance (Cronbach’s α = 0.90 in Rheumatoid Arthritis (RA) patients and 0.91 in 
Multiple Sclerosis (MS) patients), disease benefits (Cronbach’s α = 0.84 and 0.85 in RA and 
MS patients respectively), and finally helplessness (Cronbach’s α = 0.88 in both RA- and MS 
patients) 2. For each item, four response options are given, ranging from ‘disagree’ to ‘strongly 
agree’. Item scores were added up to a numerical score for each of the three scales. Each 
scale contains 6 items and the same maximum score. A high score on the acceptance and 
perceived benefit scales reflect positive cognitions regarding one’s illness. A high score on the 
helplessness scale reflects negative cognitions regarding one’s illness.
Item selection for the extended version, the ICQ-plus
For the first aim of our study, namely the exploration of illness cognitions in later life, we 
interviewed a consecutive sample of 21 older persons who had received a multidisciplinary 
diagnostic procedure by a geriatrician, psychiatrist and psychologist at our outpatient clinic 
for older persons with medically unexplained symptoms. In order to include and older 
population and to preclude contamination by early dementia, we applied the following 
inclusion criteria: 1) an age of 65 years or older, 2) adequate cognitive functioning as indicated 
by a Mini Mental State Examination (MMSE) score of 24 points or higher, and 3) a primary 
diagnosis of medically unexplained symptoms or a somatoform disorder according to 
DSM-IV-TR criteria in addition to medically explained symptoms. During the diagnostic 
process, the clinical psychologist (TvD) explored all illness cognitions of these 21 patients 
applying a semi-structured interview starting with six standardized questions. These 
questions were 1) What do you think is wrong with your body? 2) What do you think is 
causing your symptoms? 3) What do the people around you think about your symptoms? 
4) What do you consider to be the worst symptom? 5) What are your thoughts when the 
symptoms get worse? 6) Did you have similar symptoms earlier in your life?  Based on the 
initial answers given, cognitions were explored in more depth using a so-called Socratic 
dialogue. Answers on all questions were written down literally. Two psychologists registered 
as supervisors for the Dutch Society of Cognitive Behavioural Therapy, extracted all cognitions 
from the interview. Both psychologists subsequently checked which cognitions belonged to 
one of the ICQ subscales (Disease Benefits, Helplessness, Acceptance). Cognitions that were 
not captured by this classification system were coded in the category ‘other’. Cohen’s kappa 
was calculated as a measure of inter-rater agreement. Disagreement between both raters was 
resolved in discussion with a third rater (RCOV) who made the decision. 
Cognitions in the category “other” were reformulated as new items that could be added to the 
original ICQ. These items had to meet the following scale construction criteria: be positive and 
unidirectionally formulated in simple, clear language (unambiguous) in less than 20 words. 
Subsequently, all new items were given to patients and an expert panel of researchers and 
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health care professionals for comments and suggestions to improve the items. This finally 
resulted in 26 new items that were added to the original ICQ, resulting in the ICQ-plus. These 
new items had to be rated similar to the original ICQ-items on a four-point likert scale 
ranging from completely agree through completely disagree.
 
Validation of the ICQ-plus
In the second part of the study, the ICQ-plus was validated within the Older Persons with 
Medically Unexplained Symptoms (OPUS) project. As part of the OPUS project a case-control 
study was conducted, aimed at exploring biopsychosocial determinants of MUS in later life. 
The study will be summarised below:
Cases were included at baseline if they 1) were 60 years or older, 2) gave informed consent, 
and 3) met the definition for MUS of the Dutch College of General Practitioners, i.e. physical 
symptoms that have existed for more than several weeks and for which adequate medical 
examination has not revealed any condition that sufficiently explains the symptoms 8. We 
operationalized ‘several weeks’ as at least three months. Patients suffering from so-called 
functional syndromes, including fibromyalgia, chronic fatigue syndrome, irritable bowel 
syndrome or a whiplash syndrome were also considered as suffering from MUS 18. To assure 
patients met the definition of MUS, the General Practitioner (GP) was contacted to check 
whether the criteria for MUS were met. Exclusion criteria were 1) presence of primary 
psychotic disorder; 2) presence of cognitive impairment, defined as a Mini Mental State 
Examination 19 total score below 19 or an established or suspected diagnosis of dementia by 
the geriatrician or old age psychiatrist; 3) suffering from terminal illness; 4) not sufficiently 
mastering the Dutch language; and 5) severe auditory and/or visual limitations hindering 
reliable data collection. Compared to the in- and exclusion criteria of the qualitative study 
prior to the OPUS project, the in- and exclusion criteria were more liberal. First, we applied an 
age cut-off of 60 years, which is traditionally used for studies on late-life affective disorders 20. 
Secondly, we applied an MMSE of 19 or above since patients were also assessed by a geriatrician 
and an old age psychiatrist and excluded when suspect for having a cognitive disorder. Hereby 
we were able to recruit a sample of MUS patients in various developmental and severity stages. 
The control group consisted of older persons with medically explained physical symptoms. 
Inclusion criteria for this group were 1) 60 years or older, 2) informed consent, and 3) the 
presence of physical complaints for three months or longer, that could be fully explained 
by the presence of at least one chronic somatic disease, for example rheumatoid arthritis or 
asthma. The patient’s GP needed to reconfirm the explained nature of the symptoms. The 
exclusion criteria were similar to those applied for the cases. 
The recruitment process was designed to compose a sample of older patients with MUS in 
various developmental and severity stages in order to overcome setting-specific findings. 
Therefore, possible participants with MUS and MES were recruited in the community by 
advertisements in local newspapers, in primary care, and in secondary health care. To assist 
general practitioners with selecting possible participants in primary care, the top 20% of older 
frequent attending patients in their own practice were extracted from the GP Information 
System. Subsequently, the GP manually selected possible participants using the definition of 
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MUS and MES and our previously described exclusion criteria. This selection method was 
chosen based on previous research projects on MUS and other high utilizing patient groups 
in primary care 21, 22. The local Medical Ethics Committee approved the OPUS study.
A total of 118 patients with MUS (12 recruited in the community, 77 in primary care, 29 in 
specialized health care) and 154 patients with MES (11 recruited in the community, 134 in 
primary care, 9 in specialized health care) gave informed consent after having received written 
and oral information about the study procedures. Data on socio-demographic, medical, 
psychological and social characteristics were collected in two study interviews that each lasted 
between 1.0 and 1.5 hours about one week apart. 
The ICQ was administered in the second interview, which took place at the patients’ home. 
Since 26 MUS-patients and 16 MES-patients were too ill to complete the second interview, 
the ICQ data were available for 92 MUS-patients (78%) and 138 MES-patients (89.6%). The 
development of the 26 additional items was not yet finished at the time the recruitment of the 
OPUS project had started. Therefore, the first 10 patients recruited within the OPUS project 
only completed the original ICQ items, leaving 83 MUS-patients (70.3%) and 137 MES-patients 
(90.0%) that have completed the ICQ-plus. 
In addition to the ICQ-plus several other questionnaires were administered. For the present 
study, data on the primary physical complaint, socio-demographic characteristics, health related 
quality of life, depression and health anxiety were used.
Physical and Mental Health-related Quality of Life was investigated by asking the standard 
version of the 36-item Short-Form Health Survey (SF-36) 23. The 30-item version of the 
Inventory of Depressive Symptomatology Self Report questionnaire (IDS-SR) 24 was used 
to assess severity of depressive symptoms. And finally the hypochondriacal cognitions and 
somatization symptoms were additionally measured with the Whitely Index (WI) 25. These 
additional questionnaires were selected based on good psychometric properties established 
in an older population.
Statistical analyses
First, patient characteristics of the older MUS-patients and older MES-patients that completed 
the ICQ were compared by independent sample t-test for the normally distributed variable 
(age), a Mann Whitney-U test for the variable that was not normally distributed (duration of 
symptoms), and Chi Square Tests for categorical variables (sex education, partner status). 
Internal structure of the ICQ  
To determine whether or not the ICQ three factor structure was also applicable for older MES 
and MUS patients, we performed a confirmatory Maximum Likelihood factor analysis on the 
ICQ data with an extraction based on a pre-set number of factors (3) and an oblique rotation 
method (Promax).  The Root Mean Square Error of Approximation (RMSEA) is reported as 
a measure of goodness of fit. 
Furthermore, to assess if there are additional categories of illness cognitions in older MUS and 
MES-patients, we performed a series of exploratory Maximum Likelihood factor analyses based 
on the eigenvalue > 1 principle, using oblique rotation methods (Promax) on all items of the 
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ICQ and the 26 additional items. After each analysis, the RMSEA was calculated. In order to 
determine whether or not an additional factor analysis was needed, the p-value of the factor 
solution, the RMSEA and the factor structure were studied. In case of a p-value <.05 and a 
RMSEA>.05, the item that had the lowest factor loading was removed from the analysis. This 
process was repeated until a p-value >.05 or a p-value <.05 with an RMSEA <.05 was reached. 
If at this point the factor structure was clinically meaningful, no further analyses were performed. 
The final factor structure was used to create illness cognition subscale scores. 
Known group validity 
Analyses of covariance (ANCOVAs) were performed to compare illness cognitions in patients 
with MUS and patients with MES, adjusted for age, sex, education and partner status. If p-values 
were <.05, differences were considered to be statistically significant. All statistical analyses were 
performed using IBM SPSS 19.0. 
Construct validity 
In order to examine construct validity, Pearson’s correlations were explored between the ICQ 
subscale scores with the health-related quality of life, depressive symptoms and hypochondriacal 
beliefs as measured with the SF-36, IDS-SR and WI, respectively.
 Results
Item development of ICQ-plus
The semi-structured interview of the 21 patients revealed a total of 134 illness cognitions, 
ranging from two through 12 illness cognitions per patient (mean=6.4, SD=2.6). The inter-rater 
agreement of the classification of items as belonging to one of the three original ICQ-categories 
between the first and second CBT therapist was good (kappa= .73). The third rater (RCOV) 
had to classify 20 cognitions (14.9%). 
A total of 62/134 (41.3%) cognitions could be classified within the three generic categories of 
the ICQ (helplessness, acceptance and disease benefits). The 72/134 “other” cognitions were 
considered of interest for extension of the ICQ. These 72 cognitions were translated in items, 
which resulted in 26 unique items based on consensus within the research group, consultations 
of experts in the field and comments of patients (see table 1).
Patient characteristics OPUS study
Table 2 present the characteristics of the 230 participants of the OPUS study who completed 
the ICQ. Patients suffering from MUS were significantly more often female and significantly 
younger compared to patients with MES, whereas no differences were found with respect to 
marital status, education, and primary symptoms. The median of the duration of primary 
complaints was 5.0 years in MUS patients versus 2.0 years in MES patients (p<.001), with 
either 91.6% and 62.3% of the MUS and MES patients, respectively, having complaints for 




Items of the ICQ-plus 
 Item
 1. I am afraid that I have a serious illness.
 2. I can influence the severity of my physical symptoms.
 3. Despite my physical symptoms I do my utmost to finish the activities in which I am involved.
 4. I am aware that others make decisions about my physical condition.
 5. Because of my physical symptoms I see myself in a different way.
 6. I am afraid that the doctor has missed something.
 7. It is a relief to talk about my physical symptoms.
 8. Only when something can be done about my physical symptoms, will I take action.
 9. Despite my physical symptoms, I prefer to do things myself rather than ask for help.
 10. I think that I am a burden to others because of my physical symptoms.
 11. I believe that my physical symptoms influences how I look.
 12. I worry about the consequences of my physical symptoms every day.
 13. Extra rests reduces my symptoms.
 14. Despite my physical symptoms I do my utmost to continue with activities in which I am involved.
 15. I think that others consider my physical symptoms as affectation.
 16. I believe that my physical symptoms influences how I take care of myself.
 17. I expect that because of my medical state I will become dependent.
 18. Distraction helps me to deal with my physical symptoms.
 19. It is best to wait and see what the future brings regarding my health problem.
 20. Despite my physical symptoms I do my utmost to do those activities well in which I heave been involved.
 21. I think that my physical symptoms influences the lives of the people around me.
 22. I  worry about my physical symptoms will develop in the future.
 23. By avoiding pressure my physical problem is reduced.
 24. I believe that people around me understand my physical problem.
 25. I expect that my physical symptoms will get worse steadily.
 26.  I am hoping that a wonder will make my medical problem disappear.
Internal structure of the ICQ
A confirmatory Maximum Likelihood Factor Analysis with oblique rotation on the original 
18 items of the ICQ showed that the original factor structure fitted fairly well (RMSEA = .055). 
The internal consistencies for helplessness (Cronbach’s α =.920), disease benefits (Cronbach’s 
α =.874), and acceptance (Cronbach’s α =.901) were high.
Internal structure of the ICQ-plus
Table 3 shows the result of the Maximum Likelihood Factor Analysis with oblique rotation 
for the 44 potential items of the Illness Cognition Questionnaire-plus (ICQ-plus) in older 




Patient characteristics of the study sample (N=230), specified for older persons with medically 
unexplained symptoms (MUS) and older persons with medically explained symptoms (MES). 
   Older persons  Older persons
   with MUS with MES  
Characteristics  (n=93) (n=137) p valuea
Patient characteristics:    
Age Mean (SD) 70.0 (6.3) 73.0 (7.8) .002
Female sex % (n) 66.7 (62) 42.3 (58) <.001
Level of education    
• Lower % (n) 27.3 (24) 16.3 (22) .141
• Middle % (n) 46.6 (41) 53.3 (72) 
• Higher % (n) 26.1 (23) 30.4 (71) 
Partner status (yes) % (n) 61.8 (55) 61.5 (83) .962
Physical complaint:    
Primary complaint    
• pain % (n) 50.8 (60) 44.8 (69) 
• fatigue % (n) 5.1 (6) 4.5 (7) 
• palpitations % (n) 2.5 (3) 1.9 (3) 
• constipation or diarrhea  % (n) 1.7 (2) 1.3 (2) 
• many diffuse complaints % (n) 1.7 (2) 20.9 (31) 
• dizziness % (n) 0.8 (1) 2.7 (4) 
• shortness of breath % (n) 0.8 (1) 6.5 (10) 
• other % (n) 9.3 (11) 14.2 (22) 
• unknown % (n) 5.9 (7) 3.9 (6) 
Duration of complaints (years) Median (IRQ) 5.5 (10.0) 2.0 (10.0) <.001
a Significance values derived from independent samples t-tests, Mann-Whitney U-tests and chi-square tests
The three factors of the original ICQ, i.e. helplessness (Cronbach’s α =.889), disease benefits 
(Cronbach’s α =.865) and acceptance (Cronbach’s α =.896) were identified. A total of 2 original 
items did not load substantially on any factor and were removed from the list. These items 
were “dealing with my illness has made me a stronger person”, and “my illness controls my 
life”.  Furthermore 10 new items, originating from the interviews were removed. In addition, 
four additional factors were identified (see table 3). 
Based on the substantive similarities between the items within these additional factors, 
we labeled them as follows. Factor 4 (Cronbach’s α =.835) was labeled as “perseverance” 



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































keep on doing my activities”.  “I’m afraid the doctor is overseeing something” is an example 
of an item of the fifth factor (Cronbach’s α =.600) that we labeled “illness anxiety”. The sixth 
factor (Cronbach’s α =.610) could be labeled as “avoiding”; an example of an item in this 
factor is “Extra rest reduces my symptoms”.  We labeled the last factor (Cronbach’s α =.691) 
“catastrophizing”. An item of this factor is “I’m worried how my illness will be in the future”. 
Bivariate associations by Pearson’s correlation coefficients, showed that the subscale acceptance 
correlated moderately to high with helplessness (rho=-.55), disease benefits (rho=.41), 
perseverance (rho=.30), and illness anxiety (-.43) (all p-values <.001). Furthermore, the 
subscales illness anxiety and helplessness correlated moderately high (rho=.39, p<.001) as 
well as the subscales disease benefits and avoidance (rho=.38, p<.001). All other correlations 
were below .30.”
Illness cognitions scores of the ICQ-plus in MUS and MES patients (group validity).
We also compared the illness cognitions between patients with MUS and MES (see table 4). 
Analyses of covariance (ANCOVAs) showed that patients with MUS scored significantly 
higher on the subscales helplessness, and the new category illness anxiety. Patients with 
MUS scored significantly lower on acceptance and disease benefits compared to patients 
with MES, when adjusted for age, sex, educational level and partner status.
 
Table 4
Unadjusted and adjusted* mean values (with standard error of the mean) of illness cognitions of 
the ICQ plus scales by ANCOVA’s
     Subscale and Older persons Older persons p-value
     Analysis with MUS with MES
       (N=83)  (N=137) 
Acceptance Unadjusted 17.89 (0.63) 20.51 (0.48) .001
     Adjusted 18.22 (0.68) 20.16 (0.50) .025
Helplessness Unadjusted 9.82 (0.37) 8.67 (0.30) .018
     Adjusted 9.97 (0.42) 8.79 (0.33) .031
Disease benefits Unadjusted 10.47 (0.45) 11.63 (0.36) .045
     Adjusted 10.55 (0.51) 11.52 (0.39) .141
Perseverance Unadjusted 12.27 (0.37) 12.35 (0.28) .868
     Adjusted 11.98 (0.41) 12.41 (0.29) .397
Illness anxiety Unadjusted 8.30 (0.27) 7.20 (0.21) .001
     Adjusted 8.24 (0.30) 7.27 (0.22) .012
Avoidance Unadjusted 6.33 (0.25) 5.89 (0.20) .159
     Adjusted 6.47 (0.29) 5.90 (0.21) .123
Catastrophizing Unadjusted 6.62 (0.22) 6.44 (0.17) .520
     Adjusted 6.64 (0.24) 6.56 (0.18) .780




Pearson’s correlation coefficient# of all ICQ-plus subscale with health related quality of life (QoL), 
depressive symptom severity, health anxiety and duration of disease.
  Health Related QoL (SF-36) Depression Health anxiety
 
ICQ-plus subscales  Physical Mental  Inventory of Whitely Index Duration
    Depressive  of disease#
    Symptoms   
Original subscales ICQ:     
Acceptance  .39** .53** -.59** -.49** .07
Helplessness  -.48** -.49** .55** .43** .11
Disease benefits  .02 .23** -.24** -.18* -.04
Additional subscales ICQ-plus:     
Perseverance  .13 .07 -.12 -.04 .13
Illness anxiety  -.34** -.43** .46** .60** -.03
Avoidance  -.16* -.08 .09 .05 .15*
Catastrophizing  -.23** -.16* .16* .20* .17*
# Correlation with duration of disease (skewed distribution) was explored by Spearman rank correlations
* p<.05; ** p<.001
Abbreviations: SF-36, Short-Form 36; Qol, Quality of Life; ICQ, Illness Cognition Questionnaire. 
Construct Validity
Table 5 present the correlations between all ICQ-plus subscale scores with both physical and 
mental health related quality of life, depressive symptom severity, hypochondriacal beliefs, 
and duration of disease. Age did not correlate with illness cognitions, with one exception: age 
correlated with avoidance (Pearson r=-.14, p=.042). Student’s t tests revealed not significant 
difference between males and females on any of the subscales. 
 Discussion
Main conclusions
Our study confirmed the factor structure of the Illness Cognition Questionnaire in older 
patients suffering from physical symptoms. Furthermore, our qualitative study identified 26 
illness cognitions that could not be categorized as belonging to one of the established categories 
of illness cognitions and of which 16 cognitions together resulted in four new categories, that 
could be labeled as perseverance, illness anxiety, avoidance and catastrophizing. Compared to 
patients with MES, patients with MUS reported a higher level of helplessness and lower level 
of acceptance. Of the new categories, only the level of illness anxiety differed between MUS 
and MES patients, being highest in MUS patients. 
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Comparison to existing literature
The ICQ was originally based on a theoretical model of illness cognitions in patients suffering 
from long-term somatic conditions. The questionnaire was developed as a measure of giving 
meaning to a long-term somatic condition and focused consequently on cognitive components 
related to depression and adjustment problems in these populations. Thereby the 18 items 
were selected on their a priori chance to fit one of the three predefined categories of this model 2. 
This scientifically sound procedure, however, may have missed important cognitions. In 
our study, we did the opposite, by applying an empirical approach starting with a qualitative 
interview exploring all possible illness cognitions. This has resulted in 4 additional categories 
not captured by the original ICQ. Construct validity analyses showed that illness anxiety 
correlated highly with quality of life, depression and health anxiety comparable to the original 
subscales “acceptance” and “helplessness”. The other three new subscales did not, comparable 
to the original subscale “disease benefits” and thus contribute to a more comprehensive picture 
of the patient. 
Three new categories collectively reflect anxiety in the broadest sense, including cognitive 
(catastrophizing), physiological (illness anxiety) and behavioral (avoidance, perseverance) 
components. Moreover, construct validity analyses support the idea that these scales in-
deed reflect different aspects of anxiety. These anxiety-related components refer to ideas 
patients have about their future and directly interfere with actual levels of quality of life. 
Furthermore, since high anxiety levels and associated behavior place persons at risk for the 
development of psychopathology, the model seems also contribute to the explanation why 
chronic somatic conditions predispose patients to psychopathology. Moreover, the subscale 
perseverance points to a coping strategy partially based on non-acceptance of the symptoms. 
Nonetheless, construct validity shows that the subscales acceptance and perseverance are 
different constructs and thus complement each other. Composing a study sample of older 
patients suffering from either MUS or MES, irrespective of underlying somatic and/or 
psychiatric disorders maximizes heterogeneity of patients for several reasons. Firstly, it is 
generally presumed that heterogeneity between people increases with age 26, 27. As a consequence, 
illness cognitions may also become more heterogeneous. Secondly, the ICQ does not capture 
cognitions related to anxiety. Anxiety is often present with somatic symptoms, which is not 
always recognized as anxiety by doctor’s or patients’ themselves 28-30. Especially in later life, 
psychological distress is often expressed in somatic terms. For example, compared to their 
younger counterparts, older persons more often have a somatic presentation of their depression 31. 
Finally, the prevalence of somatic disorders and physical frailty increases with age. Multimorbidity 
and physical frailty are often considered the “next to last” stage of life by patients, which results 
in specific psychological challenges and cognitions related to their physical functioning 32. In 
summary, we probably selected a population with a high chance of detecting a wide range of 
cognitions related to physical functioning. Whether or not these illness cognitions are specific 
for old age, however, cannot be deducted from this study. After all, the categories perseverance, 
avoiding, catastrophizing and illness anxiety may be also be important cognitions in younger 
populations and may thus not be age specific. Moreover, the sum scores of the original scales 
of the ICQ were not associated with age 2. In our population of older patients, we also did not 
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found an association with age of the scores on the original and new subscales. Nonetheless, 
cross-validation of the ICQ-plus is warranted in younger populations before definitive 
conclusions can be drawn.
The four new categories of illness cognitions are probably clinically relevant. Catastrophic 
and hypochondric misinterpretation is seen as the central psychological determinant in the 
development and maintenance of somatic complaints 28, 33-35 and refers to a patient’s affective 
state, primarily the level of anxiety. For example, cognitions about avoidance are associated 
with the level of disability in older patient-groups with low back pain 36.
The additional categories perseverance and avoidance refer to thoughts about coping with 
illness. Perseverance, defined as “keep going on”, is an important factor in coping with chronic 
pain in later life 37. 
However we also found interesting differences between both groups. Patients with MUS 
experienced more helplessness and more illness anxiety compared to MES patients. This may 
be explained by the high co-morbidity between MUS and affective disorders such as depression 
and anxiety disorders 38. Furthermore, MUS patients mentioned less acceptance cognitions 
and disease benefits which suggests a lack of coping skills. The high co-comorbidity with 
affective disorders and the lack of coping skills in MUS patients can explain the stronger impact 
of somatic symptoms in MUS on health-related quality of life in patients suffering from MUS 
than in patients with MES 9.
 
Methodological considerations
A strength of our study is a bottom-up exploring of illness cognitions in a population that 
can be considered as highly relevant for clinical practice where many patients are old. 
Subsequently, we validated these illness cognitions in a large sample of older patients suffering 
from explained and/or unexplained physical symptoms. Nonetheless, for proper interpretation 
of our results, some methodological limitations should be taken into account. Firstly, the 
qualitative study did not include patients suffering from MES only. This a priori choice was 
based on the fact that we expected the highest variability and most maladaptive cognitions 
among MUS patients. Acknowledging the minimal differences between MUS- and MES-patients, 
MES patients were at least as relevant to include. Moreover, it is possible that we not have captured 
the most relevant illness cognitions of patients with MES only. Secondly, new categories are 
based on only a low number of items per subscale, i.e. 4, 5, 3, and 3 items respectively. Based 
on face-validity for potentially clinical relevance, we decided to accept the low number of 
items per subscale as well as the fact that three items of the ICQ-plus (item 25, 26 and 29) also 
cross-loaded on other subscales. This may explain the relatively low level of reliability of the 
subscales “illness anxiety”, “avoiding”, and “catastrophizing”, although Cronbach’s α for these 
three subscales is still above 0.60, which is acceptable for (very) short scales. Further research, 
however, is needed to confirm these subscales in other samples. Investigators specifically 
interested in these subscales should preferably conduct a confirmatory factor analysis on their 
data and check the reliability estimates. Ideally, each subscale should be extended with additional 
items to make it more robust. 
Secondly, although we extended the ICQ in an older sample and we a priori thought to find 
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age-specific cognitions, most cognitions do not seem to be age-specific at face value. This is in 
line with previous studies on the ICQ in which no correlations with age have been found 2, 5. 
Nonetheless, comparison with a younger sample is needed for definitive conclusions.
Implications/conclusion
In this study, we identified additional cognition-categories for older patients with physical 
symptoms (explained and/or unexplained) which are not captured by the ICQ. For this reason, 
we propose an extension of the scale, which we call the ICQ-plus (see appendices). The ICQ-plus 
may help therapists in exploring all potential cognitions that need to be challenged during 
Cognitive Behavioural Therapy for treating MUS and MES in later life. In future studies, especially 
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